Atlas Trials

Efficacy and Toxicity of Paclitaxel, Cisplatin Combined With Sindilimab in NACT for Locally Advanced Cervical Cancer

Clinical trial NCT04799639 · COMPLETED

Trial details

NCT number
NCT04799639
Sponsor
Sun Yat-sen University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cervical CancerChemotherapy EffectProgrammed Cell Death 1 Receptor / Antagonists & InhibitorsNeoadjuvant Therapy
Start date
2021-03-18
Primary completion
2024-06-17
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.